Document is current
Any future updates will be listed below
-
Authors
Sommers, Thomas https://orcid.org/0000-0002-1300-8234
Yaeger, Amaryah
Lin, David
Marchlinski, Francis
Nazarian, Saman
-
Funding
Funding for this research was provided by:
Pennsylvania Steel Company EP Research Fund
Winkelman Family Fund in Cardiovascular Innovation
- License Information
-
More Information
Article History
Received: 31 December 2022
Accepted: 6 March 2023
First Online: 15 March 2023
Declarations
:
: This study was performed under a protocol approved by the Institutional Review Board (IRB) at the University of Pennsylvania. Informed consent was waved per IRB protocol given the retrospective nature of the study.
: Dr. Nazarian is a consultant for CardioSolv and Circle CVI and serves as a principal investigator for research funding from Biosense Webster, ImriCor, ADAS software, and the US NIH. Dr. Marchlinski has served as consultant for Abbott Medical, Boston Scientific, Medtronic, and Biotronik Inc and has received research support from Biosense Webster. The University of Pennsylvania Conflict of Interest Committee manages all commercial arrangements. The other authors report no conflicts of interest.
